A NEW IDEA ON PTC THERAPEUTICS $PTCT
This post was just published on ZYX Short Change Alert. There are reports from England of issues with a promising drug trial for duchenne muscular dystrophy. If the rumors are true, the stock can easily fall to $30 to $37. Consider short selling up to 30% of the full core position size in